Wisniewski A, Fléjou JF, Siproudhis L, Abramowitz L, Svrcek M, Beaugerie L. Anal neoplasia in inflammatory bowel disease: classification proposal, epidemiology, carcinogenesis, and risk management perspectives. J Crohns Colitis. 2017;11(8):1011-8. doi: 10.1093/ecco-jcc/jjx035. [PubMed: 28379306].

Egea-Valenzuela J, Belchí-Segura E, Essouri N, Sánchez-Torres A, Carballo-Alvarez F. Adenocarcinoma of the rectum and anus in a patient with Crohn's disease treated with infliximab. Rev Esp Enferm Dig. 2010;102(8):501-4. doi: 10.4321/s1130-01082010000800009. [PubMed: 20670073].

Maejima T, Kono T, Orii F, Maemoto A, Furukawa S, Liming W, et al. Anal Canal adenocarcinoma in a patient with longstanding Crohn's disease arising from rectal mucosa that migrated from a previously treated rectovaginal fistula. Am J Case Rep. 2016;17:448-53. doi: 10.12659/ajcr.897876. [PubMed: 27373845].

Melichar B, Bures J, Dedic K. Anorectal carcinoma after infliximab therapy in Crohn's disease: report of a case. Dis Colon Rectum. 2006;49(8):1228-33. doi: 10.1007/s10350-006-0647-6. [PubMed: 16845561].

Freeman HJ, Perry T, Webber DL, Chang SD, Loh MY. Mucinous carcinoma in Crohn's disease originating in a fistulous tract. World J Gastrointest Oncol. 2010;2(7):307-10. doi: 10.4251/wjgo.v2.i7.307. [PubMed: 21160662].

Lightner AL, Moncrief SB, Smyrk TC, Pemberton JH, Haddock MG, Larson DW, et al. Long-standing Crohn's disease and its implication on anal squamous cell cancer management. Int J Colorectal Dis. 2017;32(5):661–6. doi: 10.1007/s00384-017-2794-8. [PubMed: 28293746].

Buchman AL, Ament ME, Doty J. Development of squamous cell carcinoma in chronic perineal sinus and wounds in Crohn's disease. Am J Gastroenterol. 1991;86(12):1829-32. [PubMed: 1962632].

Benjelloun EB, Abkari M, Ousadden A, Ait Taleb K. Squamous cell carcinoma associated anal fistulas in Crohn's disease unique case report with literature review. J Crohns

Colitis. 2013;7(6):232-5. doi: 10.1016/j.crohns.2012.09.015. [PubMed: 23069004].

Ball CS, Wujanto R, Haboubi NY, Schofield PF. Carcinoma in anal Crohn's disease: discussion paper. J R Soc Med. 1988;81(4):217-9. doi: 10.1177/014107688808100411. [PubMed: 3373467].

Daly JJ, Madrazo A. Anal Crohn's disease with carcinoma in situ. Dig Dis Sci. 1980;25(6):464-6. doi: 10.1007/BF01395512. [PubMed: 7379680].

Barral M, Dohan A, Allez M, Boudiaf M, Camus M, Laurent V, et al. Gastrointestinal cancers in inflammatory bowel disease: An update with emphasis on imaging findings.

Crit Rev Oncol Hematol. 2016;97:30-46. doi: 10.1016/j.critrevonc.2015.08.005. [PubMed: 26315381].

Wisniewski A, Fléjou JF, Siproudhis L, Abramowitz L, Svrcek M, Beaugerie L. Anal Neoplasia in Inflammatory Bowel Disease: Classification Proposal, Epidemiology, Carcinogenesis, and Risk Management Perspectives. J Crohns Colitis. 2017 Aug 1;11(8):1011-1018. doi: 10.1093/ecco-jcc/jjx035. PMID: 28379306.

Wisniewski A, Fléjou JF, Siproudhis L, Abramowitz L, Svrcek M, Beaugerie L. Anal Neoplasia in Inflammatory Bowel Disease: Classification Proposal, Epidemiology, Carcinogenesis, and Risk Management Perspectives. J Crohns Colitis. 2017 Aug 1;11(8):1011-1018. doi: 10.1093/ecco-jcc/jjx035. PMID: 28379306.

Devon KM, Brown CJ, Burnstein M, McLeod RS. Cancer of the anus complicating perianal Crohn's disease. Dis Colon Rectum. 2009;52(2):211-6. doi: 10.1007/DCR.0b013e318197d0ad. [PubMed: 19279414].

Beaugerie L, Carrat F, Nahon S, Zeitoun JD, Sabaté JM, Peyrin-Biroulet L, et al. High risk of anal and rectal cancer in patients with anal and/or perianal Crohn's Disease. Clin Gastroenterol Hepatol. 2018;16(6):892-9. doi: 10.1016/j.cgh.2017.11.041. [PubMed: 29199142].

Ogawa H, Haneda S, Shibata C, Miura K, Nagao M, Ohnuma S, et al. Adenocarcinoma associated with perianal fistulas in Crohn's disease. Anticancer Res. 2013;33(2):685-9. [PubMed: 23393368].

Cohen RB, Dittrich KA. Anti-TNF therapy and malignancy - a critical review. Can J Gastroenterol. 2001;15(6):376-84. doi: 10.1155/2001/403102. [PubMed: 11429667].

Malvi D, Vasuri F, Mattioli B, Gruppioni E, Fiorentino M, Gionchetti P, et al. Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. Pathology. 2014;46(5):439-43. doi: 10.1097/PAT.0000000000000123. [PubMed: 24977730].

Biancone L, Orlando A, Kohn A, Colombo E, Sostegni R, Angelucci E, et al. Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. Gut. 2006;55(2):228-33. doi: 10.1136/gut.2005.075937. [PubMed: 16120759].

Biancone L, Calabrese E, Petruzziello C, Pallone F. Treatment with biologic therapies and the risk of cancer in patients with IBD. Nat Clin Pract Gastroenterol Hepatol. 2007;4(2):78-91. doi: 10.1038/ncpgasthep0695. [PubMed: 17268543].